NO325688B1 - Sarbandasje til kontroll av alvorlig blodning og fremgangsmate til fremstilling derav. - Google Patents

Sarbandasje til kontroll av alvorlig blodning og fremgangsmate til fremstilling derav. Download PDF

Info

Publication number: NO325688B1
Authority: NO; Norway
Prior art keywords: chitosan; wound dressing; wound; bleeding; blood
Prior art date: 2001-06-14

Application number

NO20035569A

Other languages

English (en)

Norwegian (no)

Other versions

NO20035569D0 (no

NO20035569L (no

Inventor

Simon Mccarthy

Kenton W Gregory

Original Assignee

Providence Health System Oregon

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-14

Filing date

2003-12-12

Publication date

2008-07-07

2003-12-12 Application filed by Providence Health System Oregon filed Critical Providence Health System Oregon

2003-12-12 Publication of NO20035569D0 publication Critical patent/NO20035569D0/no

2004-02-12 Publication of NO20035569L publication Critical patent/NO20035569L/no

2008-07-07 Publication of NO325688B1 publication Critical patent/NO325688B1/no

Links

238000000034 method Methods 0.000 title claims abstract description 27
230000000740 bleeding effect Effects 0.000 title claims description 74
238000002360 preparation method Methods 0.000 title description 2
229920001661 Chitosan Polymers 0.000 claims abstract description 124
239000012620 biological material Substances 0.000 claims abstract description 38
238000004519 manufacturing process Methods 0.000 claims description 13
238000004108 freeze drying Methods 0.000 claims description 9
239000002861 polymer material Substances 0.000 claims description 5
238000003825 pressing Methods 0.000 claims description 3
230000008569 process Effects 0.000 claims description 3
230000003750 conditioning effect Effects 0.000 claims 1
230000023597 hemostasis Effects 0.000 abstract description 13
230000000712 assembly Effects 0.000 abstract 1
238000000429 assembly Methods 0.000 abstract 1
230000035876 healing Effects 0.000 abstract 1
229920001477 hydrophilic polymer Polymers 0.000 abstract 1
230000003239 periodontal effect Effects 0.000 abstract 1
239000002993 sponge (artificial) Substances 0.000 abstract 1
208000027418 Wounds and injury Diseases 0.000 description 250
206010052428 Wound Diseases 0.000 description 225
208000032843 Hemorrhage Diseases 0.000 description 105
239000008280 blood Substances 0.000 description 53
210000004369 blood Anatomy 0.000 description 52
238000012360 testing method Methods 0.000 description 42
239000000463 material Substances 0.000 description 31
241001465754 Metazoa Species 0.000 description 30
208000014674 injury Diseases 0.000 description 30
230000006378 damage Effects 0.000 description 28
239000000243 solution Substances 0.000 description 22
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 20
238000004090 dissolution Methods 0.000 description 18
238000007710 freezing Methods 0.000 description 16
230000008014 freezing Effects 0.000 description 16
230000001070 adhesive effect Effects 0.000 description 15
230000017531 blood circulation Effects 0.000 description 13
239000010410 layer Substances 0.000 description 13
-1 poly(glycolic acid) Polymers 0.000 description 13
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
239000000853 adhesive Substances 0.000 description 12
239000000203 mixture Substances 0.000 description 12
210000000952 spleen Anatomy 0.000 description 12
108090000190 Thrombin Proteins 0.000 description 11
230000002439 hemostatic effect Effects 0.000 description 11
229960004072 thrombin Drugs 0.000 description 11
238000007906 compression Methods 0.000 description 10
230000006835 compression Effects 0.000 description 10
239000012530 fluid Substances 0.000 description 10
230000001976 improved effect Effects 0.000 description 10
230000004083 survival effect Effects 0.000 description 9
238000001816 cooling Methods 0.000 description 8
230000034994 death Effects 0.000 description 8
231100000517 death Toxicity 0.000 description 8
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 7
230000004520 agglutination Effects 0.000 description 7
229960002897 heparin Drugs 0.000 description 7
229920000669 heparin Polymers 0.000 description 7
210000001519 tissue Anatomy 0.000 description 7
229920002101 Chitin Polymers 0.000 description 6
229960000583 acetic acid Drugs 0.000 description 6
210000000709 aorta Anatomy 0.000 description 6
238000002474 experimental method Methods 0.000 description 6
239000007789 gas Substances 0.000 description 6
238000010438 heat treatment Methods 0.000 description 6
210000004185 liver Anatomy 0.000 description 6
239000004800 polyvinyl chloride Substances 0.000 description 6
229920000915 polyvinyl chloride Polymers 0.000 description 6
230000003393 splenic effect Effects 0.000 description 6
235000011054 acetic acid Nutrition 0.000 description 5
238000007872 degassing Methods 0.000 description 5
210000003811 finger Anatomy 0.000 description 5
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
241000191967 Staphylococcus aureus Species 0.000 description 4
230000001464 adherent effect Effects 0.000 description 4
238000010171 animal model Methods 0.000 description 4
229940030225 antihemorrhagics Drugs 0.000 description 4
210000001367 artery Anatomy 0.000 description 4
230000037396 body weight Effects 0.000 description 4
230000035602 clotting Effects 0.000 description 4
210000003414 extremity Anatomy 0.000 description 4
239000004744 fabric Substances 0.000 description 4
239000006260 foam Substances 0.000 description 4
238000009472 formulation Methods 0.000 description 4
239000002609 medium Substances 0.000 description 4
210000004379 membrane Anatomy 0.000 description 4
239000012528 membrane Substances 0.000 description 4
239000012071 phase Substances 0.000 description 4
229920000642 polymer Polymers 0.000 description 4
239000011148 porous material Substances 0.000 description 4
230000002829 reductive effect Effects 0.000 description 4
238000001179 sorption measurement Methods 0.000 description 4
230000008733 trauma Effects 0.000 description 4
206010002091 Anaesthesia Diseases 0.000 description 3
206010053567 Coagulopathies Diseases 0.000 description 3
102000008186 Collagen Human genes 0.000 description 3
108010035532 Collagen Proteins 0.000 description 3
108010073385 Fibrin Proteins 0.000 description 3
102000009123 Fibrin Human genes 0.000 description 3
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 3
PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 3
208000034693 Laceration Diseases 0.000 description 3
206010067125 Liver injury Diseases 0.000 description 3
241000282887 Suidae Species 0.000 description 3
241000282898 Sus scrofa Species 0.000 description 3
239000002253 acid Substances 0.000 description 3
230000002411 adverse Effects 0.000 description 3
230000037005 anaesthesia Effects 0.000 description 3
210000002376 aorta thoracic Anatomy 0.000 description 3
230000023555 blood coagulation Effects 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
229920001436 collagen Polymers 0.000 description 3
238000009826 distribution Methods 0.000 description 3
230000000694 effects Effects 0.000 description 3
210000003743 erythrocyte Anatomy 0.000 description 3
238000011156 evaluation Methods 0.000 description 3
229950003499 fibrin Drugs 0.000 description 3
230000012010 growth Effects 0.000 description 3
229960002725 isoflurane Drugs 0.000 description 3
238000002350 laparotomy Methods 0.000 description 3
239000004620 low density foam Substances 0.000 description 3
239000000843 powder Substances 0.000 description 3
238000011160 research Methods 0.000 description 3
150000003839 salts Chemical class 0.000 description 3
238000007789 sealing Methods 0.000 description 3
210000003491 skin Anatomy 0.000 description 3
239000007787 solid Substances 0.000 description 3
239000002904 solvent Substances 0.000 description 3
230000001954 sterilising effect Effects 0.000 description 3
238000004659 sterilization and disinfection Methods 0.000 description 3
230000000699 topical effect Effects 0.000 description 3
230000002792 vascular Effects 0.000 description 3
210000003462 vein Anatomy 0.000 description 3
238000009736 wetting Methods 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
206010002899 Aortic injury Diseases 0.000 description 2
XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
206010060964 Arterial haemorrhage Diseases 0.000 description 2
206010003162 Arterial injury Diseases 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
208000031737 Tissue Adhesions Diseases 0.000 description 2
210000001015 abdomen Anatomy 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
229920000615 alginic acid Polymers 0.000 description 2
235000010443 alginic acid Nutrition 0.000 description 2
238000000540 analysis of variance Methods 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
150000001450 anions Chemical class 0.000 description 2
230000010100 anticoagulation Effects 0.000 description 2
210000000702 aorta abdominal Anatomy 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
235000010323 ascorbic acid Nutrition 0.000 description 2
239000011668 ascorbic acid Substances 0.000 description 2
230000008901 benefit Effects 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
210000001715 carotid artery Anatomy 0.000 description 2
125000002091 cationic group Chemical group 0.000 description 2
210000004027 cell Anatomy 0.000 description 2
230000006196 deacetylation Effects 0.000 description 2
238000003381 deacetylation reaction Methods 0.000 description 2
230000007547 defect Effects 0.000 description 2
238000011161 development Methods 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
238000001035 drying Methods 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
210000003195 fascia Anatomy 0.000 description 2
210000001105 femoral artery Anatomy 0.000 description 2
238000005227 gel permeation chromatography Methods 0.000 description 2
239000001963 growth medium Substances 0.000 description 2
210000004247 hand Anatomy 0.000 description 2
230000002008 hemorrhagic effect Effects 0.000 description 2
239000002874 hemostatic agent Substances 0.000 description 2
231100000234 hepatic damage Toxicity 0.000 description 2
231100000753 hepatic injury Toxicity 0.000 description 2
ROBFUDYVXSDBQM-UHFFFAOYSA-N hydroxymalonic acid Chemical compound OC(=O)C(O)C(O)=O ROBFUDYVXSDBQM-UHFFFAOYSA-N 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
239000007791 liquid phase Substances 0.000 description 2
230000008818 liver damage Effects 0.000 description 2
230000033001 locomotion Effects 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
229910052757 nitrogen Inorganic materials 0.000 description 2
WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
239000013641 positive control Substances 0.000 description 2
238000001878 scanning electron micrograph Methods 0.000 description 2
238000000926 separation method Methods 0.000 description 2
239000001632 sodium acetate Substances 0.000 description 2
235000017281 sodium acetate Nutrition 0.000 description 2
238000009987 spinning Methods 0.000 description 2
238000003756 stirring Methods 0.000 description 2
239000000758 substrate Substances 0.000 description 2
239000002344 surface layer Substances 0.000 description 2
238000001356 surgical procedure Methods 0.000 description 2
229940052907 telazol Drugs 0.000 description 2
QAXBVGVYDCAVLV-UHFFFAOYSA-N tiletamine Chemical compound C=1C=CSC=1C1(NCC)CCCCC1=O QAXBVGVYDCAVLV-UHFFFAOYSA-N 0.000 description 2
230000029663 wound healing Effects 0.000 description 2
PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
229920001651 Cyanoacrylate Polymers 0.000 description 1
241000238557 Decapoda Species 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 1
108010049003 Fibrinogen Proteins 0.000 description 1
102000008946 Fibrinogen Human genes 0.000 description 1
238000000729 Fisher's exact test Methods 0.000 description 1
BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
VPNYRYCIDCJBOM-UHFFFAOYSA-M Glycopyrronium bromide Chemical compound [Br-].C1[N+](C)(C)CCC1OC(=O)C(O)(C=1C=CC=CC=1)C1CCCC1 VPNYRYCIDCJBOM-UHFFFAOYSA-M 0.000 description 1
206010019677 Hepatic haemorrhage Diseases 0.000 description 1
208000001953 Hypotension Diseases 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
229920002201 Oxidized cellulose Polymers 0.000 description 1
241001494479 Pecora Species 0.000 description 1
239000004952 Polyamide Substances 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
229920000954 Polyglycolide Polymers 0.000 description 1
241000238425 Polyplacophora Species 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
108010094028 Prothrombin Proteins 0.000 description 1
102100027378 Prothrombin Human genes 0.000 description 1
229920002125 Sokalan® Polymers 0.000 description 1
206010041649 Splenic injury Diseases 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
238000000692 Student's t-test Methods 0.000 description 1
208000002847 Surgical Wound Diseases 0.000 description 1
208000029224 Thoracic injury Diseases 0.000 description 1
108010000499 Thromboplastin Proteins 0.000 description 1
102000002262 Thromboplastin Human genes 0.000 description 1
208000007536 Thrombosis Diseases 0.000 description 1
206010067979 Traumatic liver injury Diseases 0.000 description 1
238000010162 Tukey test Methods 0.000 description 1
208000025865 Ulcer Diseases 0.000 description 1
206010065441 Venous haemorrhage Diseases 0.000 description 1
206010047228 Venous injury Diseases 0.000 description 1
230000003187 abdominal effect Effects 0.000 description 1
230000004308 accommodation Effects 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000004523 agglutinating effect Effects 0.000 description 1
229940072056 alginate Drugs 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
229910052786 argon Inorganic materials 0.000 description 1
230000004872 arterial blood pressure Effects 0.000 description 1
229940072107 ascorbate Drugs 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
229940125717 barbiturate Drugs 0.000 description 1
230000006399 behavior Effects 0.000 description 1
238000005452 bending Methods 0.000 description 1
229920002988 biodegradable polymer Polymers 0.000 description 1
239000004621 biodegradable polymer Substances 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
208000015294 blood coagulation disease Diseases 0.000 description 1
230000036772 blood pressure Effects 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
BPKIGYQJPYCAOW-FFJTTWKXSA-I calcium;potassium;disodium;(2s)-2-hydroxypropanoate;dichloride;dihydroxide;hydrate Chemical compound O.[OH-].[OH-].[Na+].[Na+].[Cl-].[Cl-].[K+].[Ca+2].C[C@H](O)C([O-])=O BPKIGYQJPYCAOW-FFJTTWKXSA-I 0.000 description 1
239000002775 capsule Substances 0.000 description 1
229960001631 carbomer Drugs 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
235000015165 citric acid Nutrition 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
239000000515 collagen sponge Substances 0.000 description 1
230000001010 compromised effect Effects 0.000 description 1
230000001143 conditioned effect Effects 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000011109 contamination Methods 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
238000005336 cracking Methods 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
229920006237 degradable polymer Polymers 0.000 description 1
210000004207 dermis Anatomy 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
238000005553 drilling Methods 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
238000001523 electrospinning Methods 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
229940049268 euthasol Drugs 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
238000001125 extrusion Methods 0.000 description 1
229940012952 fibrinogen Drugs 0.000 description 1
238000005187 foaming Methods 0.000 description 1
210000005224 forefinger Anatomy 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
230000006870 function Effects 0.000 description 1
239000000499 gel Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
239000012362 glacial acetic acid Substances 0.000 description 1
MSWZFWKMSRAUBD-IVMDWMLBSA-N glucosamine group Chemical group OC1[C@H](N)[C@@H](O)[C@H](O)[C@H](O1)CO MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
239000003292 glue Substances 0.000 description 1
229930195712 glutamate Natural products 0.000 description 1
229940015042 glycopyrrolate Drugs 0.000 description 1
230000000025 haemostatic effect Effects 0.000 description 1
230000036541 health Effects 0.000 description 1
210000002989 hepatic vein Anatomy 0.000 description 1
235000011167 hydrochloric acid Nutrition 0.000 description 1
239000000416 hydrocolloid Substances 0.000 description 1
208000021822 hypotensive Diseases 0.000 description 1
230000001077 hypotensive effect Effects 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
238000007654 immersion Methods 0.000 description 1
239000007943 implant Substances 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
239000011261 inert gas Substances 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000036512 infertility Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
239000002054 inoculum Substances 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
210000004731 jugular vein Anatomy 0.000 description 1
230000002147 killing effect Effects 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
230000003902 lesion Effects 0.000 description 1
239000007788 liquid Substances 0.000 description 1
DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
238000001000 micrograph Methods 0.000 description 1
239000000178 monomer Substances 0.000 description 1
229950006780 n-acetylglucosamine Drugs 0.000 description 1
239000012299 nitrogen atmosphere Substances 0.000 description 1
238000001543 one-way ANOVA Methods 0.000 description 1
229940107304 oxidized cellulose Drugs 0.000 description 1
238000012856 packing Methods 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
239000002245 particle Substances 0.000 description 1
230000037361 pathway Effects 0.000 description 1
230000009518 penetrating injury Effects 0.000 description 1
230000035515 penetration Effects 0.000 description 1
229960001412 pentobarbital Drugs 0.000 description 1
230000010412 perfusion Effects 0.000 description 1
210000003200 peritoneal cavity Anatomy 0.000 description 1
239000002831 pharmacologic agent Substances 0.000 description 1
238000000614 phase inversion technique Methods 0.000 description 1
238000005191 phase separation Methods 0.000 description 1
239000008055 phosphate buffer solution Substances 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
229920000747 poly(lactic acid) Polymers 0.000 description 1
229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 1
229920002627 poly(phosphazenes) Polymers 0.000 description 1
229920002647 polyamide Polymers 0.000 description 1
229920001610 polycaprolactone Polymers 0.000 description 1
239000000622 polydioxanone Substances 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920000139 polyethylene terephthalate Polymers 0.000 description 1
239000005020 polyethylene terephthalate Substances 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
239000004814 polyurethane Substances 0.000 description 1
229920002635 polyurethane Polymers 0.000 description 1
239000003361 porogen Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
238000009101 premedication Methods 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
229960000957 prothipendyl Drugs 0.000 description 1
229940039716 prothrombin Drugs 0.000 description 1
239000005297 pyrex Substances 0.000 description 1
230000005855 radiation Effects 0.000 description 1
230000008439 repair process Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
238000007493 shaping process Methods 0.000 description 1
238000002791 soaking Methods 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
238000010911 splenectomy Methods 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
238000010186 staining Methods 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000008107 starch Substances 0.000 description 1
238000007619 statistical method Methods 0.000 description 1
238000013190 sterility testing Methods 0.000 description 1
210000001562 sternum Anatomy 0.000 description 1
238000003860 storage Methods 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
238000004781 supercooling Methods 0.000 description 1
230000008961 swelling Effects 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
230000035488 systolic blood pressure Effects 0.000 description 1
238000012353 t test Methods 0.000 description 1
238000009864 tensile test Methods 0.000 description 1
CWERGRDVMFNCDR-UHFFFAOYSA-M thioglycolate(1-) Chemical compound [O-]C(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-M 0.000 description 1
210000000115 thoracic cavity Anatomy 0.000 description 1
210000003813 thumb Anatomy 0.000 description 1
229960004523 tiletamine Drugs 0.000 description 1
230000017423 tissue regeneration Effects 0.000 description 1
230000008736 traumatic injury Effects 0.000 description 1
231100000397 ulcer Toxicity 0.000 description 1
210000003932 urinary bladder Anatomy 0.000 description 1
230000009278 visceral effect Effects 0.000 description 1
229920003169 water-soluble polymer Polymers 0.000 description 1
238000009941 weaving Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00987—Apparatus or processes for manufacturing non-adhesive dressings or bandages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00987—Apparatus or processes for manufacturing non-adhesive dressings or bandages
- A61F13/00991—Apparatus or processes for manufacturing non-adhesive dressings or bandages for treating webs, e.g. for moisturising, coating, impregnating or applying powder
- A61F13/00995—Apparatus or processes for manufacturing non-adhesive dressings or bandages for treating webs, e.g. for moisturising, coating, impregnating or applying powder for mechanical treatments
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01008—Non-adhesive bandages or dressings characterised by the material
- A61F13/01012—Non-adhesive bandages or dressings characterised by the material being made of natural material, e.g. cellulose-, protein-, collagen-based
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01034—Non-adhesive bandages or dressings characterised by a property
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/15203—Properties of the article, e.g. stiffness or absorbency
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00106—Wound bandages emergency bandages, e.g. for first aid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00463—Plasters use haemostatic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00463—Plasters use haemostatic
- A61F2013/00468—Plasters use haemostatic applying local pressure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00463—Plasters use haemostatic
- A61F2013/00472—Plasters use haemostatic with chemical means
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00536—Plasters use for draining or irrigating wounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/0054—Plasters use for deep wounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/00927—Plasters containing means with biological activity, e.g. enzymes for debriding wounds or others, collagen or growth factors
- A61F2013/00931—Plasters containing means with biological activity, e.g. enzymes for debriding wounds or others, collagen or growth factors chitin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Materials Engineering (AREA)
Hematology (AREA)
Manufacturing & Machinery (AREA)
Dispersion Chemistry (AREA)
Materials For Medical Uses (AREA)
Controlling Rewinding, Feeding, Winding, Or Abnormalities Of Webs (AREA)
Storage Of Web-Like Or Filamentary Materials (AREA)
Dental Preparations (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Polymers & Plastics (AREA)
Organic Chemistry (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

NO20035569A 2001-06-14 2003-12-12 Sarbandasje til kontroll av alvorlig blodning og fremgangsmate til fremstilling derav. NO325688B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US29877301P	2001-06-14	2001-06-14
PCT/US2002/018757 WO2002102276A2 (fr)	2001-06-14	2002-06-14	Pansement pour blessure et methode de controle des saignements importants constituant un danger de mort

Publications (3)

Publication Number	Publication Date
NO20035569D0 NO20035569D0 (no)	2003-12-12
NO20035569L NO20035569L (no)	2004-02-12
NO325688B1 true NO325688B1 (no)	2008-07-07

Family

ID=23151953

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20035569A NO325688B1 (no)	2001-06-14	2003-12-12	Sarbandasje til kontroll av alvorlig blodning og fremgangsmate til fremstilling derav.

Country Status (14)

Country	Link
US (3)	US7482503B2 (fr)
EP (1)	EP1401352B1 (fr)
JP (1)	JP4332030B2 (fr)
KR (2)	KR100953465B1 (fr)
AT (1)	ATE549996T1 (fr)
AU (1)	AU2002312493B2 (fr)
BR (1)	BR0210406A (fr)
CA (1)	CA2450668C (fr)
DK (1)	DK1401352T3 (fr)
IL (2)	IL159339A0 (fr)
NO (1)	NO325688B1 (fr)
NZ (1)	NZ530399A (fr)
WO (1)	WO2002102276A2 (fr)
ZA (1)	ZA200309861B (fr)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7897832B2 (en) *	2001-06-14	2011-03-01	Hemcon Medical Technologies, Inc.	Compositions, assemblies, and methods applied during or after a dental procedure to ameliorate fluid loss and/or promote healing, using a hydrophilic polymer sponge structure such as chitosan
US7371403B2 (en) *	2002-06-14	2008-05-13	Providence Health System-Oregon	Wound dressing and method for controlling severe, life-threatening bleeding
US8741335B2 (en)	2002-06-14	2014-06-03	Hemcon Medical Technologies, Inc.	Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan
BR0210406A (pt)	2001-06-14	2006-04-04	Providence Health Sys Oregon	curativo de ferimento, e, métodos de controle de sangramento severo, e de produção de um curativo de ferimento capaz de controlar o sangramento severo
US20050147656A1 (en) *	2001-06-14	2005-07-07	Hemcon, Inc.	Tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan
US20060004314A1 (en) *	2001-06-14	2006-01-05	Hemcon, Inc.	Antimicrobial barriers, systems, and methods formed from hydrophilic polymer structures such as chistosan
US8269058B2 (en) *	2002-06-14	2012-09-18	Hemcon Medical Technologies, Inc.	Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan
US20050137512A1 (en) *	2003-12-23	2005-06-23	Campbell Todd D.	Wound dressing and method for controlling severe, life-threatening bleeding
US7943810B2 (en) *	2003-02-04	2011-05-17	Buckman Robert F	Method and apparatus for hemostasis
JP4496360B2 (ja) *	2003-04-24	2010-07-07	国立大学法人九州大学	医療用高分子ナノ・マイクロファイバー
CN1835723B (zh) *	2003-06-16	2011-06-22	洛马林达大学医学中心	可展开的多功能止血剂
WO2005062896A2 (fr) *	2003-12-23	2005-07-14	Hemcon, Inc.	Ensembles, systemes et procedes destines a des pansements en tissu formes a partir de structures spongieuses polymeres hydrophiles telles qu'un chitosane
SE0303588D0 (sv) *	2003-12-30	2003-12-30	Bioactive Polymers Ab C O Lund	Surface protection of exposed biological tissues
DE102004007115A1 (de) *	2004-02-13	2005-08-25	Cognis Deutschland Gmbh & Co. Kg	Chitosanhaltige Wundauflagen
WO2005087280A1 (fr) *	2004-03-11	2005-09-22	Medtrade Products Limited	Compositions de $g(a)- et $g(b)-chitosanes et leurs procedes de preparation
WO2006022358A1 (fr) *	2004-08-24	2006-03-02	Teijin Limited	Corps stratifié
BRPI0519404A2 (pt) *	2004-12-23	2009-01-20	Hemcon Inc	barreiras antimicrobianas, sistemas e mÉtodos formados a partir de estruturas polimÉricas hidrofÍlicas tais como a quitosana
US9204957B2 (en)	2005-03-17	2015-12-08	Hemcon Medical Technologies, Inc.	Systems and methods for hemorrhage control and or tissue repair
KR20080030094A (ko) *	2005-07-13	2008-04-03	헴콘, 인크.	키토산과 같은 친수성 중합체 포움으로부터 형성된 입상지혈제를 사용하는 지혈 조성물, 집합체, 시스템 및 방법
CA2518298A1 (fr) *	2005-09-06	2007-03-06	Chaimed Technologies Inc.	Polymeres biodegradables, leur preparation et leur usage pour la fabrication de pansements
GB0526505D0 (en)	2005-12-29	2006-02-08	Medtrade Products Ltd	Hemostatic material
JP5160102B2 (ja) *	2006-02-14	2013-03-13	甲陽ケミカル株式会社	非晶質の部分脱アセチル化キチン塩のスポンジ状止血材及びその製造方法
CA2643083A1 (fr) *	2006-03-01	2007-09-13	Fmc Biopolymer As	Mousse biodegradable
DE102006020498A1 (de) *	2006-04-20	2007-10-25	Aesculap Ag & Co. Kg	Schichtförmige Wundauflage
JP2009538192A (ja) *	2006-05-23	2009-11-05	プロビデンスヘルスシステム−オレゴンディー／ビー／エープロビデンスセントビンセントメディカルセンター	体の内腔または体の中空器官内に包帯構造を導入および適用するシステムおよび方法
WO2008036225A2 (fr) *	2006-09-20	2008-03-27	Entek Manufacturing, Inc.	Pansement thérapeutique structuré conformable
US8623842B2 (en) *	2006-09-27	2014-01-07	Hemostasis, Llc	Hemostatic agent and method
US8414550B2 (en)	2006-09-29	2013-04-09	Lexion Medical, Llc	System and method to vent gas from a body cavity
FR2909862B1 (fr) *	2006-12-13	2009-02-06	Christophe Tanvier	Pansement et collier a bille anti-hemorragie arterielle
US8932560B2 (en)	2007-09-04	2015-01-13	University of Maryland, College Parke	Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
US9066885B2 (en) *	2007-03-16	2015-06-30	University Of Maryland, College Park	Advanced functional biocompatible polymeric matrix containing nano-compartments
US8585646B2 (en)	2008-03-03	2013-11-19	Lexion Medical, Llc	System and method to vent gas from a body cavity
US9061087B2 (en) *	2008-03-04	2015-06-23	Hemostasis, Llc	Method of making a hemostatic sponge wound dressing comprising subjecting the sponge to water vapor
AU2015202401B2 (en) *	2008-04-25	2016-06-16	Medtrade Products Limited	Haemostatic material
GB2461019B (en)	2008-04-25	2013-06-05	Medtrade Products Ltd	Haemostatic material
AU2009241687A1 (en) *	2008-05-02	2009-11-05	Providence Health System-Oregon D/B/A Providence St. Vincent Medical Center	Wound dressing devices and methods
GB2463523B (en) *	2008-09-17	2013-05-01	Medtrade Products Ltd	Wound care device
EP2340002B1 (fr)	2008-10-06	2015-03-25	Providence Health System - Oregon	Dispositifs médicaux en mousse et procédés
US9452088B2 (en)	2009-03-26	2016-09-27	Medical Devices, Inc.	Vented emergency wound dressings
USRE48007E1 (en)	2009-03-26	2020-05-26	Medical Devices, Inc.	Vented emergency wound dressings
US20110052663A1 (en) *	2009-09-01	2011-03-03	Hemostasis, Llc	Hemostatic Sponge with Enzyme and Method of Manufacture
US10207022B2 (en)	2009-09-01	2019-02-19	Medoderm Gmbh	Chitosan tissue dressing
US8642088B2 (en)	2009-09-04	2014-02-04	Wisconsin Alumni Research Foundation	Tannin-chitosan composites
CN106913902A (zh)	2009-11-09	2017-07-04	聚光灯技术合伙有限责任公司	多糖基水凝胶
CA2780898A1 (fr)	2009-11-13	2011-05-19	University Of Maryland, College Park	Mousse biocompatible fonctionnelle innovante utilisee comme agent hemostatique pour plaies aigues compressibles et non compressibles
EP2504039A4 (fr) *	2009-11-25	2014-07-02	Univ Loma Linda Med	Textile hemostatique a base de chitosane
EP2394670A1 (fr)	2010-06-04	2011-12-14	Université de Liège	Échafaudages biomimétiques à base de chitosane et leurs procédés de préparation
CA2808454A1 (fr)	2010-08-13	2012-02-16	University Of Maryland, College Park	Methode et systeme pour inverser les interactions entre des biopolymeres a modification hydrophobe et des vesicules ou des membranes cellulaires
WO2012075457A2 (fr)	2010-12-02	2012-06-07	University Of Maryland, College Park	Procédé et système de capture et d'utilisation de vésicules intactes sur des pellicules de biopolymères hydrophobiquement modifiés électrodéposés
GB201104175D0 (en) *	2011-03-11	2011-04-27	Medtrade Products Ltd	Haemostatic material
CN103619363B (zh) *	2011-07-10	2016-05-25	科洛普拉斯特公司	带有凝血酶的伤口敷料
EP2734213B1 (fr) *	2011-07-19	2018-06-06	Baxalta GmbH	Activateurs de résorption comme additifs pour améliorer la formulation orale de polysaccharides sulfatés non anticoagulants
AU2012318259A1 (en)	2011-10-11	2013-05-02	Baxter Healthcare S.A.	Hemostatic compositions
US8809614B2 (en) *	2012-01-16	2014-08-19	Jerry M. Wilhoit	Dental wound dressing
US9168178B2 (en)	2012-05-22	2015-10-27	Covidien Lp	Energy-delivery system and method for controlling blood loss from wounds
FR2994185B1 (fr)	2012-08-02	2015-07-31	Sofradim Production	Procede de preparation d’une couche poreuse a base de chitosane
US9072625B2 (en)	2012-11-01	2015-07-07	Genuine First Aid International, Ltd.	Easy access bandages, packaging, and systems for application
DE102012021655B4 (de)	2012-11-03	2023-03-30	Hof Sonderanlagenbau Gmbh	Verfahren zur Gefriertrocknung eines mit einem Lösungsmittel versehenen, feuchten Produktes
CN103100107B (zh) *	2013-01-25	2014-08-20	安吉县阳光医药用品有限责任公司	一种几丁质医用生物敷料的制备方法
CA2914610C (fr)	2013-03-13	2022-08-02	University Of Maryland	Pate polymere biocompatible fonctionnelle avancee utilisee comme agent hemostatique pour le traitement de tissu et de cellules endommages
US9040093B2 (en)	2013-03-13	2015-05-26	Orthovita, Inc.	Bone graft materials containing calcium phosphate and chitosan
EP3569262A1 (fr)	2013-03-14	2019-11-20	Tricol Biomedical, Inc.	Compositions biocompatibles et biorésorbables de chitosane dérivé
GB2514597A (en) *	2013-05-30	2014-12-03	Medtrade Products Ltd	Degradable haemostat composition
GB2514592A (en) *	2013-05-30	2014-12-03	Medtrade Products Ltd	Degradable haemostat composition
US9358256B2 (en)	2013-07-11	2016-06-07	Links Medical Products, Inc.	Gap-patterned foam dressing and method of making same
CN103520765B (zh) *	2013-11-06	2015-04-01	中国科学院长春应用化学研究所	一种创伤止血敷料的制备方法
EP3107590B1 (fr)	2014-02-20	2021-11-17	Ortho Regenerative Technologies Inc.	Compositions polymères lyophilisées à mélanger avec un plasma riche en plaquettes en vue de former des implants pour une réparation tissulaire et/ou compositions pour infiltrations intra-articulaires thérapeutiques
US9259357B2 (en)	2014-04-16	2016-02-16	Loma Linda University	Composition, preparation, and use of chitosan shards for biomedical applications
CN104225683B (zh) *	2014-07-09	2016-07-06	广州迈普再生医学科技有限公司	加载三七的止血组织修复膜及其制备方法
GB2543672A (en) *	2014-08-13	2017-04-26	Essentra Porous Tech Corp	Anti-microbial foams containing polymer-stabilized silver nanoparticles
US20180214160A1 (en) *	2015-01-09	2018-08-02	Tricol Biomedical, Inc.	Percutaneous vascular injury treatment systems and methods
GB201501333D0 (en)	2015-01-27	2015-03-11	Medtrade Products Ltd	Composition for a wound dressing
GB201501330D0 (en) *	2015-01-27	2015-03-11	Medtrade Products Ltd	Composition for a wound dressing
US9314243B1 (en)	2015-04-06	2016-04-19	King Saud University	Gingival graft stabilizer
CN108601860A (zh)	2016-02-12	2018-09-28	金珂生物医疗公司	壳聚糖超细纤维系统
CN106075551B (zh) *	2016-06-22	2019-03-29	武汉纺织大学	一种互穿网络型白芨多糖膜的制备方法
WO2018116052A1 (fr)	2016-12-20	2018-06-28	Innovative Nano & Micro Technologies Pvt Ltd (Inm Technologies),	Compositions d'échafaudage pour réparation tissulaire
WO2018167622A1 (fr) *	2017-03-11	2018-09-20	Azista Industries Pvt Ltd	Procédé pour la préparation d'éponge de pansement
KR101878769B1 (ko)	2017-04-03	2018-08-16	조석형	저분자 cm-1,3-베타글루칸 칼슘염 분말 지혈제
US10881754B2 (en) *	2017-04-19	2021-01-05	Benjamin S. Paras	Disposable antiseptic wipe apparatus
WO2018232051A1 (fr) *	2017-06-13	2018-12-20	Healthdent Technology International, Inc.	Inserts absorbants pour cavités dentaires
US11033361B2 (en) *	2017-10-19	2021-06-15	Ormco Corporation	Methods for orthodontic treatment planning with augmented visual analysis
US12156791B2 (en)	2017-12-29	2024-12-03	Tricol Biomedical, Inc.	Chitosan dressing for control of bleeding in transurethral prostatectomy
US11660236B2 (en)	2017-12-29	2023-05-30	Tricol Biomedical, Inc.	Delivery systems for control of bleeding in transurethral prostatectomy
WO2019133898A1 (fr)	2017-12-29	2019-07-04	Tricol Biomedical, Inc.	Pansement à base de chitosane pour le contrôle du saignement gastro-intestinal
WO2019133894A1 (fr)	2017-12-29	2019-07-04	Tricol Biomedical, Inc.	Systèmes de pose pour prise en charge des hémorragies gastro-intestinales
CN111787892B (zh) *	2017-12-29	2025-02-18	金珂生物医疗公司	抵抗溶解的组织粘附脱乙酰壳多糖材料
US10758594B2 (en)	2018-06-26	2020-09-01	Marine Essence Biosciences Corporation of USA	Biomaterial devices and topical compositions for treatment of skin abnormalities
US10912822B2 (en)	2018-06-26	2021-02-09	Marine Essence Biosciences Corporation of USA	Biomaterial devices and topical compositions for guided tissue regeneration
CN109009688A (zh) *	2018-09-05	2018-12-18	中国人民解放军第二军医大学	极地用急救携带物
US20220062335A1 (en) *	2019-01-28	2022-03-03	Hyprotek, Inc.	Antimicrobial composition with procoagulant, immunomodulatory, and tissue regenerative properties
US12403157B2 (en)	2019-03-05	2025-09-02	Medcura, Inc.	System and method to reduce tissue ororgan adhesion
US12234578B2 (en)	2020-01-29	2025-02-25	Wisconsin Alumni Research Foundation	Tannin composite fibers
US12326378B2 (en)	2020-06-25	2025-06-10	Xmetix Ltd.	Injury detection wearable system
US12303564B2 (en)	2021-03-19	2025-05-20	Wisconsin Alumni Research Foundation	Composite chitosan-tannin-active agent compositions and methods of making and using same
CN113846419B (zh) *	2021-10-14	2022-09-13	北京化工大学	一种抗菌消毒纳米纤维医用敷料及制备方法
CN114177346B (zh) *	2021-12-24	2023-05-26	中国人民解放军军事科学院军事医学研究院	一种止血组合物及止血贴与其应用
CN114533942B (zh) *	2022-02-25	2022-10-04	上海交通大学	一种多糖止血材料和制备方法及其应用
CN115887740B (zh) *	2022-10-08	2024-02-20	湖南中腾湘岳生物科技有限公司	一种多孔止血粉及其制备方法
KR102926215B1 (ko) *	2023-04-06	2026-02-10	이-쿤 오우	유리 치은 이식 키트
CN119455067B (zh) *	2025-01-14	2025-09-30	四川大学	一种复合孔结构胶原蛋白止血海绵及其制备方法

Family Cites Families (154)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US483327A (en) *		1892-09-27		John j
US2610625A (en)	1947-10-14	1952-09-16	Armour & Co	Surgical sponge and the preparation thereof
US2858830A (en) *	1956-10-01	1958-11-04	Frank C Lowe	Surgical dressing
US2923664A (en) *	1957-09-11	1960-02-02	Johnson & Johnson	Hemostatic product
DE1617393C2 (de)	1966-01-06	1982-11-11	&Ccaron;eskoslovenská akademie v&ecaron;d, Praha	Verfahren zur Herstellung von biologisch aktive Stoffe enthaltenden hydrophilen vernetzten Copolymeren
US3632754A (en)	1968-02-12	1972-01-04	Lescarden Ltd	Use of chitin for promoting wound healing
US3801675A (en)	1970-02-20	1974-04-02	Johnson & Johnson	Polymer blend containing polyacrylic acid,polyvinyl alcohol,and a polyacrylate
US3911116A (en)	1970-04-13	1975-10-07	Leslie L Balassa	Process for promoting wound healing with chitin derivatives
US3849238A (en)	1972-04-07	1974-11-19	S Ronel	Artificial skin
US3800792A (en) *	1972-04-17	1974-04-02	Johnson & Johnson	Laminated collagen film dressing
US3954493A (en) *	1972-10-19	1976-05-04	Avicon, Inc.	Regenerated cellulose sponge
US3902497A (en)	1974-03-25	1975-09-02	American Cyanamid Co	Body absorbable sponge and method of making
US4040884A (en) *	1974-06-19	1977-08-09	American Cyanamid Company	Medical sponges
US3977406A (en) *	1974-06-19	1976-08-31	American Cyanamid Company	Medical sponges
CH596233A5 (fr) *	1975-04-10	1978-03-15	Nestle Sa
US4068757A (en)	1976-11-03	1978-01-17	American Cyanamid Company	Chitin derived powder in sterile surgical element package
US4056103A (en)	1977-03-11	1977-11-01	Kimberly-Clark Corporation	Wrapper structure for tampons containing superabsorbent material
US4195175A (en)	1978-01-03	1980-03-25	Johnson Edwin L	Process for the manufacture of chitosan
JPS6239506Y2 (fr)	1979-07-28	1987-10-08
US4292972A (en) *	1980-07-09	1981-10-06	E. R. Squibb & Sons, Inc.	Lyophilized hydrocolloio foam
US4394373A (en)	1981-04-06	1983-07-19	Malette William Graham	Method of achieving hemostasis
US4532134A (en)	1981-04-06	1985-07-30	Malette William Graham	Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
US4460642A (en)	1981-06-26	1984-07-17	Minnesota Mining And Manufacturing Company	Water-swellable composite sheet of microfibers of PTFE and hydrophilic absorptive particles
US4373519A (en) *	1981-06-26	1983-02-15	Minnesota Mining And Manufacturing Company	Composite wound dressing
US4533326A (en) *	1981-08-10	1985-08-06	Anthony Albert J	Oral pack retention system
US4759348A (en) *	1981-09-28	1988-07-26	Cawood Charles David	Endoscope assembly and surgical instrument for use therewith
EP0075791B1 (fr) *	1981-09-30	1986-04-09	VEB Leipziger Arzneimittelwerk	Pansement vulnéraire absorbant et procédés de sa fabrication
US4501835A (en)	1982-03-08	1985-02-26	Polaroid Corporation	Polyacrylic acid/chitosan polyelectrolyte complex
JPS58206751A (ja) *	1982-05-26	1983-12-02	日石三菱株式会社	創傷被覆材
US4973493A (en)	1982-09-29	1990-11-27	Bio-Metric Systems, Inc.	Method of improving the biocompatibility of solid surfaces
US4452785A (en)	1982-11-08	1984-06-05	Malette William Graham	Method for the therapeutic occlusion
EP0122085B1 (fr)	1983-04-06	1987-06-24	Smith and Nephew Associated Companies p.l.c.	Pansement
US4958011A (en) *	1983-06-27	1990-09-18	Bade Maria L	Ester-stabilized chitin
JPS6090507U (ja)	1983-11-29	1985-06-21	トヨタ自動車株式会社	ダブルオ−バヘツドカムシヤフト型エンジンのバルブ開閉タイミング可変装置
JPS60142927A (ja) *	1983-12-28	1985-07-29	Lion Corp	医療用バンド
JPS6114622A (ja) *	1984-06-29	1986-01-22	Yamaichi Electric Mfg Co Ltd	電気光学結晶体の電圧印加機構
DE3527482A1 (de)	1984-07-31	1986-02-06	Fuji Spinning Co., Ltd., Tokio/Tokyo	Verfahren zum herstellen von koernigem poroesen chitosan
EP0171254B1 (fr) *	1984-08-03	1991-06-19	Unitika Ltd.	Objet moulé à partir de chitine
SE8501022L (sv)	1985-03-01	1986-09-02	Pharmacia Ab	Format alster och forfarande for dess framstellning
JPS61240963A (ja) *	1985-04-18	1986-10-27	ユニチカ株式会社	創傷被覆保護材
JPS61253065A (ja) *	1985-05-02	1986-11-10	片倉チツカリン株式会社	キトサン誘導体およびコラ−ゲンの複合材の医用材料およびその製造法
US4684370A (en) *	1985-10-02	1987-08-04	Barrett Garret D	Stents for bone augmentation by surgical implant
US4960413A (en) *	1985-11-09	1990-10-02	The Shirley Institute	Wound dressing
US5300494A (en) *	1986-06-06	1994-04-05	Union Carbide Chemicals & Plastics Technology Corporation	Delivery systems for quaternary and related compounds
CA1326416C (fr)	1986-08-25	1994-01-25	Ralph Xavier Ewall	Pansements de polymere
JPH0751603B2 (ja) *	1986-10-03	1995-06-05	ユニチカ株式会社	キトサンスポンジ
JPS6390507U (fr)	1986-11-29	1988-06-11
US5252275A (en) *	1991-03-07	1993-10-12	Weyerhauser Company	Method of densifying crosslinked fibers
US5254301A (en) *	1988-03-29	1993-10-19	Ferris Mfg. Corp.	Process for preparing a sheet of polymer-based foam
US4952618A (en) *	1988-05-03	1990-08-28	Minnesota Mining And Manufacturing Company	Hydrocolloid/adhesive composition
US5006071A (en)	1988-05-09	1991-04-09	Carter Dewey G	Technique for the prevention of alveolar osteitis
US5110604A (en) *	1988-06-30	1992-05-05	Collagen Corporation	Processes for producing collagen matrixes and methods of using same
US5024841A (en) *	1988-06-30	1991-06-18	Collagen Corporation	Collagen wound healing matrices and process for their production
CA1340190C (fr) *	1988-08-01	1998-12-15	The Kendall Company	Surface adhesive discontinue
US4948540A (en) *	1988-08-01	1990-08-14	Semex Medical, Inc.	Method of preparing collagen dressing sheet material
US4956350A (en)	1988-08-18	1990-09-11	Minnesota Mining And Manufacturing Company	Wound filling compositions
JPH06104116B2 (ja) *	1988-11-29	1994-12-21	三菱化成株式会社	創傷被覆材
US5062418A (en)	1989-01-31	1991-11-05	Johnson & Johnson Medical, Inc.	Napped nonwoven fabric having high bulk and absorbency
JPH07116241B2 (ja)	1989-02-08	1995-12-13	サッポロビール株式会社	米糠由来生理活性多糖ｒｏｎの製造法
GB2228682B (en)	1989-02-23	1992-08-12	Ultra Lab Ltd	Wound dressing
CA2030593C (fr)	1989-12-29	2002-03-26	Donald H. Lucast	Pansement multi-couches
JP2579610B2 (ja)	1990-09-28	1997-02-05	鳥取大学長	生体内充填剤
IT1243260B (it) *	1990-11-26	1994-05-26	Riccardo Muzzarelli	Metil pirrolidon chitosano, processo di produzione e suo uso.
US6054122A (en) *	1990-11-27	2000-04-25	The American National Red Cross	Supplemented and unsupplemented tissue sealants, methods of their production and use
US5206028A (en) *	1991-02-11	1993-04-27	Li Shu Tung	Dense collagen membrane matrices for medical uses
US5804213A (en) *	1991-10-09	1998-09-08	Lectec Corporation	Biologically active aqueous gel wound dressing
US5525710A (en) *	1991-12-20	1996-06-11	Alliedsignal Inc.	Highly porous chitosan bodies
US5376376A (en)	1992-01-13	1994-12-27	Li; Shu-Tung	Resorbable vascular wound dressings
GB9206509D0 (en)	1992-03-25	1992-05-06	Jevco Ltd	Heteromorphic sponges containing active agents
US5326350A (en) *	1992-05-11	1994-07-05	Li Shu Tung	Soft tissue closure systems
US5840777A (en)	1992-06-19	1998-11-24	Albany International Corp.	Method of producing polysaccharide foams
US5454719A (en)	1992-08-03	1995-10-03	Hamblen; Lamae E.	Sterile dental packs and method of utilizing same
US5458884A (en)	1992-09-10	1995-10-17	Britton; Peter	Bioerodible device for administering active ingredients
JP3863913B2 (ja) *	1992-12-01	2006-12-27	スリーエムカンパニー	永続性抗菌剤
US5797960A (en) *	1993-02-22	1998-08-25	Stevens; John H.	Method and apparatus for thoracoscopic intracardiac procedures
DE4322956C2 (de) *	1993-07-09	1995-12-21	Haack Karl Werner An	Folie aus Chitosan zur Wundversiegelung
DK94693D0 (da) *	1993-08-19	1993-08-19	Coloplast As	Ikke-fibroest poroest materiale, saarbandage omfattende en saadan bandage samt fremgangsmaade til fremstilling af materialet
US5387206A (en)	1993-08-27	1995-02-07	Merocel Corporation	Mechanical treatment of dry sponge material to impart flexibility
CA2175203A1 (fr) *	1993-11-03	1995-05-11	Thaddeus P. Pruss	Tampon hemostatique
US5858350A (en)	1993-12-01	1999-01-12	Marine Polymer Technologies	Methods and compositions for poly-β-1→4-N-acetylglucosamine cell therapy system
US5420197A (en) *	1994-01-13	1995-05-30	Hydromer, Inc.	Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives
US5560878A (en) *	1994-11-30	1996-10-01	The Procter & Gamble Company	Method and apparatus for making stretchable absorbent articles
US5634936A (en) *	1995-02-06	1997-06-03	Scimed Life Systems, Inc.	Device for closing a septal defect
CA2224253A1 (fr) *	1995-06-09	1996-12-27	Martin J. Macphee	Hydrogels de chitine, leurs procedes de fabrication et leur utilisation
US5827265A (en) *	1996-02-07	1998-10-27	Regents Of The University Of California	Intraluminal tissue welding for anastomosis
JP2822174B2 (ja) *	1996-03-01	1998-11-11	オーミケンシ株式会社	キチンキトサン繊維及び構造体の製造法
US5952618A (en)	1996-07-11	1999-09-14	Deslauriers; Richard J.	Acoustic conduit for use with a stethoscope
US5836970A (en)	1996-08-02	1998-11-17	The Kendall Company	Hemostatic wound dressing
US6485667B1 (en)	1997-01-17	2002-11-26	Rayonier Products And Financial Services Company	Process for making a soft, strong, absorbent material for use in absorbent articles
NL1005812C1 (nl) *	1997-04-15	1997-06-04	Claus Jurgen Timmermans	Superabsorberend wondverband.
WO1998051711A1 (fr)	1997-05-14	1998-11-19	Japan As Represented By Director General Of National Institute Of Sericultural And Entomological Science Ministry Of Agriculture, Forestry And Fisherries	Perles de chitine, perles de chitosane, leur procede de production, vehicule comprenant lesdites perles, et procede de preparation d'une spore de microsporidie
ATE247990T1 (de)	1997-07-02	2003-09-15	Coloplast As	Herstellungsmethode für ein faserfreies, poröses material
EP0996664A1 (fr)	1997-07-09	2000-05-03	Huntsman Ici Chemicals Llc	Mousses comprimees hydrophiles de polyurethanne
ZA987019B (en)	1997-08-06	1999-06-04	Focal Inc	Hemostatic tissue sealants
FR2776518B1 (fr) *	1998-03-24	2002-11-29	Oreal	Patch a matrice adhesive
US6042877A (en)	1998-07-28	2000-03-28	3M Innovative Properties Company	Method for the manufacture of anti-microbial articles
US6454787B1 (en) *	1998-12-11	2002-09-24	C. R. Bard, Inc.	Collagen hemostatic foam
GB9900348D0 (en) *	1999-01-09	1999-02-24	Bristol Myers Squibb Co	Multi layered wound dressing
GB2348136B (en)	1999-03-24	2003-06-04	Johnson & Johnson Medical Ltd	Wound dressings having low adherency
JP5031144B2 (ja) *	1999-03-25	2012-09-19	メタボリックス，インコーポレイテッド	ポリヒドロキシアルカノエートポリマーの医療デバイスおよび医療適用
US6726712B1 (en) *	1999-05-14	2004-04-27	Boston Scientific Scimed	Prosthesis deployment device with translucent distal end
KR100721752B1 (ko)	2000-01-24	2007-05-25	쿠라레 메디카루 가부시키가이샤	수팽윤성 고분자 겔 및 그 제조법
DE10009248C2 (de)	2000-02-28	2002-06-27	Freudenberg Carl Kg	Medizinisches Verbandsmaterial
AU2000231640A1 (en) *	2000-03-03	2001-09-12	Rolf Siegel	Agent for the treatment of wounds
US6309454B1 (en)	2000-05-12	2001-10-30	Johnson & Johnson Medical Limited	Freeze-dried composite materials and processes for the production thereof
CA2416126C (fr)	2000-07-28	2011-07-05	Anika Therapeutics, Inc.	Composites bioabsorbables d'acide hyaluronique derive
JP2002233542A (ja)	2001-02-09	2002-08-20	Shiseido Co Ltd	創傷被覆材及びその製造方法
US20020161376A1 (en) *	2001-04-27	2002-10-31	Barry James J.	Method and system for delivery of coated implants
BR0210406A (pt)	2001-06-14	2006-04-04	Providence Health Sys Oregon	curativo de ferimento, e, métodos de controle de sangramento severo, e de produção de um curativo de ferimento capaz de controlar o sangramento severo
US20050147656A1 (en) *	2001-06-14	2005-07-07	Hemcon, Inc.	Tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan
US7371403B2 (en) *	2002-06-14	2008-05-13	Providence Health System-Oregon	Wound dressing and method for controlling severe, life-threatening bleeding
US7897832B2 (en) *	2001-06-14	2011-03-01	Hemcon Medical Technologies, Inc.	Compositions, assemblies, and methods applied during or after a dental procedure to ameliorate fluid loss and/or promote healing, using a hydrophilic polymer sponge structure such as chitosan
US8741335B2 (en) *	2002-06-14	2014-06-03	Hemcon Medical Technologies, Inc.	Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan
US20060004314A1 (en)	2001-06-14	2006-01-05	Hemcon, Inc.	Antimicrobial barriers, systems, and methods formed from hydrophilic polymer structures such as chistosan
WO2003007944A1 (fr) *	2001-07-20	2003-01-30	Qlt, Inc.	Traitement d'oedemes maculaires par therapie photodynamique
GB2382775B (en)	2001-12-06	2005-05-25	Johnson & Johnson Medical Ltd	Controlled release therapeutic wound dressings
CN1642505A (zh)	2002-03-21	2005-07-20	陶氏环球技术公司	设计包含高吸收性聚合物的干燥和多孔吸收复合材料
US6693180B2 (en)	2002-04-04	2004-02-17	China Textile Institute	Composite sponge wound dressing made of β-Chitin and Chitosan and method for producing the same
AU2003221580A1 (en)	2002-04-30	2003-11-17	Her Majesty The Queen, In Right Of Canada, As Represented By The Minister Of National Defence Of Her	Multi-layer synthetic dressing with cooling characteristics
US6992233B2 (en) *	2002-05-31	2006-01-31	Medafor, Inc.	Material delivery system
WO2003101310A1 (fr)	2002-06-04	2003-12-11	Christy Cummins	Clip de fermeture pour vaisseau sanguin et dispositif d'apport
US20050137512A1 (en)	2003-12-23	2005-06-23	Campbell Todd D.	Wound dressing and method for controlling severe, life-threatening bleeding
US20070066920A1 (en) *	2002-06-14	2007-03-22	Hemcon Medical Technologies, Inc.	Supple tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan
JP4648704B2 (ja) *	2002-09-30	2011-03-09	ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム	ステントデリバリーシステムとその使用方法。
WO2004047695A1 (fr)	2002-11-26	2004-06-10	Coloplast A/S	Pansement
US6863924B2 (en) *	2002-12-23	2005-03-08	Kimberly-Clark Worldwide, Inc.	Method of making an absorbent composite
EP1587502B2 (fr)	2002-12-31	2025-05-21	BSN medical GmbH	Pansement pour blessure
DE602004032514D1 (de) *	2003-01-09	2011-06-16	Polyganics Bv	Biomedizinische schäume
US7019191B2 (en)	2003-03-25	2006-03-28	Ethicon, Inc.	Hemostatic wound dressings and methods of making same
US7637934B2 (en)	2003-03-31	2009-12-29	Merit Medical Systems, Inc.	Medical appliance optical delivery and deployment apparatus and method
US20050036955A1 (en)	2003-08-13	2005-02-17	Degould Michael D.	Bioresorbable tooth extraction socket dressing
US7674837B2 (en) *	2003-09-08	2010-03-09	Fmc Biopolymer As	Gelled biopolymer based foam
TW200526276A (en)	2003-10-31	2005-08-16	Basf Ag	Polymeric particles capable of absorbing blood and/or body fluids
US8133500B2 (en) *	2003-12-04	2012-03-13	Kensey Nash Bvf Technology, Llc	Compressed high density fibrous polymers suitable for implant
CA2557042C (fr)	2004-02-23	2013-06-25	Loma Linda University Medical Center	Agent hemostatique a usage topique et interne
US20050278010A1 (en) *	2004-05-27	2005-12-15	Scimed Life Systems, Inc.	Stent delivery system with imaging capability
US7402172B2 (en) *	2004-10-13	2008-07-22	Boston Scientific Scimed, Inc.	Intraluminal therapeutic patch
US20060083710A1 (en) *	2004-10-18	2006-04-20	Joerger Melissa C	Process for making antimicrobial polymer articles
KR20060040329A (ko)	2004-11-05	2006-05-10	나건	내시경을 통하여 도포 가능한 체내 지혈제 및 그 도포 방법
US20070083137A1 (en) *	2004-12-23	2007-04-12	Hemcon Medical Technologies, Inc.	Supple tissue dressing assemblies, systems, and methods formed from softened hydrophilic polymer sponge structures such as chitosan
US7161056B2 (en)	2005-01-28	2007-01-09	Ossur Hf	Wound dressing and method for manufacturing the same
US9204957B2 (en) *	2005-03-17	2015-12-08	Hemcon Medical Technologies, Inc.	Systems and methods for hemorrhage control and or tissue repair
CN1833732A (zh)	2005-03-17	2006-09-20	李毅彬	一种抗菌医用敷料的制造方法及其用途
US7536962B2 (en) *	2005-04-19	2009-05-26	Kamterter Ii, L.L.C.	Systems for the control and use of fluids and particles
KR20080030094A (ko)	2005-07-13	2008-04-03	헴콘, 인크.	키토산과 같은 친수성 중합체 포움으로부터 형성된 입상지혈제를 사용하는 지혈 조성물, 집합체, 시스템 및 방법
WO2007056066A2 (fr)	2005-11-04	2007-05-18	Lifescience Plus, Inc.	Gaze hémostatique bioabsorbable
GB0526505D0 (en)	2005-12-29	2006-02-08	Medtrade Products Ltd	Hemostatic material
US20070237811A1 (en)	2006-04-10	2007-10-11	Scherr George H	Chitosan wound dressing
US20070255243A1 (en)	2006-04-28	2007-11-01	Kaun James M	Dimensionally stable stretchable absorbent composite
US20070276308A1 (en)	2006-05-26	2007-11-29	Huey Raymond J	Hemostatic agents and devices for the delivery thereof
CN101138648A (zh)	2006-09-07	2008-03-12	电子科技大学中山学院	含抗菌止血中药生物敷料的制造方法
AU2007294765A1 (en)	2006-09-13	2008-03-20	Hemcon Medical Technologies, Inc.	Supple tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan
WO2008036225A2 (fr)	2006-09-20	2008-03-27	Entek Manufacturing, Inc.	Pansement thérapeutique structuré conformable
US20080147019A1 (en) *	2006-12-19	2008-06-19	Kimberly-Clark Worldwide, Inc.	Antimicrobial component system containing metallic nanoparticles and chitosan and/or its derivatives

2002
- 2002-06-14 BR BRPI0210406-7A patent/BR0210406A/pt not_active Application Discontinuation
- 2002-06-14 CA CA2450668A patent/CA2450668C/fr not_active Expired - Fee Related
- 2002-06-14 WO PCT/US2002/018757 patent/WO2002102276A2/fr not_active Ceased
- 2002-06-14 EP EP02739871A patent/EP1401352B1/fr not_active Expired - Lifetime
- 2002-06-14 DK DK02739871.8T patent/DK1401352T3/da active
- 2002-06-14 ZA ZA200309861A patent/ZA200309861B/xx unknown
- 2002-06-14 JP JP2003504865A patent/JP4332030B2/ja not_active Expired - Lifetime
- 2002-06-14 US US10/480,827 patent/US7482503B2/en not_active Expired - Fee Related
- 2002-06-14 AT AT02739871T patent/ATE549996T1/de active
- 2002-06-14 KR KR1020037016418A patent/KR100953465B1/ko not_active Expired - Fee Related
- 2002-06-14 AU AU2002312493A patent/AU2002312493B2/en not_active Ceased
- 2002-06-14 NZ NZ530399A patent/NZ530399A/en unknown
- 2002-06-14 IL IL15933902A patent/IL159339A0/xx unknown
- 2002-06-14 KR KR1020097001826A patent/KR100953466B1/ko not_active Expired - Fee Related
2003
- 2003-12-11 IL IL159339A patent/IL159339A/en not_active IP Right Cessation
- 2003-12-12 NO NO20035569A patent/NO325688B1/no not_active IP Right Cessation
2007
- 2007-10-31 US US11/981,111 patent/US7820872B2/en not_active Expired - Fee Related
2010
- 2010-07-12 US US12/804,010 patent/US9004918B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ATE549996T1 (de)	2012-04-15
EP1401352B1 (fr)	2012-03-21
US7820872B2 (en)	2010-10-26
CA2450668A1 (fr)	2002-12-27
AU2002312493B2 (en)	2007-08-09
CA2450668C (fr)	2010-05-04
KR100953465B1 (ko)	2010-04-16
IL159339A (en)	2012-06-28
NO20035569D0 (no)	2003-12-12
ZA200309861B (en)	2004-12-20
BR0210406A (pt)	2006-04-04
WO2002102276A2 (fr)	2002-12-27
IL159339A0 (en)	2004-06-01
US7482503B2 (en)	2009-01-27
NO20035569L (no)	2004-02-12
JP4332030B2 (ja)	2009-09-16
KR20090017704A (ko)	2009-02-18
DK1401352T3 (da)	2012-06-25
WO2002102276A3 (fr)	2003-05-01
JP2005503197A (ja)	2005-02-03
NZ530399A (en)	2006-08-31
US20080064998A1 (en)	2008-03-13
KR20040027519A (ko)	2004-04-01
KR100953466B1 (ko)	2010-04-16
US9004918B2 (en)	2015-04-14
EP1401352A4 (fr)	2009-09-02
EP1401352A2 (fr)	2004-03-31
US20050038369A1 (en)	2005-02-17
US20110143312A1 (en)	2011-06-16

Legal Events

Date	Code	Title	Description
2011-01-31	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO325688B1 (no)	2008-07-07	Sarbandasje til kontroll av alvorlig blodning og fremgangsmate til fremstilling derav.
JP4854084B2 (ja)	2012-01-11	創傷被覆材および生命を脅かす重篤な出血を抑制するための方法
US8313474B2 (en)	2012-11-20	Method for preparing a compressed wound dressing
AU2002312493A1 (en)	2003-05-15	Wound dressing and method for controlling severe, life-threatening bleeding
BR112020016382A2 (pt)	2020-12-15	Composição hemostática, método de fabricação da mesma, e, método de hemostasia
EP4401799A1 (fr)	2024-07-24	Échafaudage de type spongieux pour la promotion de l'hémostase